April 20, 2026
Claret Bioscience and New England Biolabs (NEB® ) have entered into a co-promotion agreement to support researchers using SRSLY® MethylPlus in combination with the NEBNext® EM-seq™ v2 Conversion Module. SRSLY MethylPlus and SRSLY Uracil+ products are designed to integrate with enzymatic methyl-conversion workflows, enabling high-quality library preparation for methylation profiling and fragmentomics research. The collaboration [...]
April 20, 2026
VANCOUVER, British Columbia -- ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M seed funding round led by Wittington Ventures. Additionally, new investors Continuum Health Ventures and Mayo Clinic contributed alongside repeat investors RiSC Capital, Debiopharm, [...]
Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand
April 20, 2026
After a decade of implementing laboratory systems for regulated labs, company consolidates under the Labbit name to focus entirely on its modern LIMS platform VANCOUVER, BC - Labbit, a laboratory information management system (LIMS) built for regulated laboratories running complex workflows, today announced it has retired the Semaphore Solutions brand and consolidated operations under the [...]
April 20, 2026
Orion HT and Orion LE extend the Orion platform from assay development through clinical trials, backed by an expanding biomarker reagent portfolio and commercial leadership focused on global growth SEATTLE -- RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of [...]
April 20, 2026
Expanded footprint delivers speed, scale and customization minimal residual disease (MRD) innovators need without compromising quality Increased production capacity leverages IDT’s highly specialized, high-throughput manufacturing platform CORALVILLE, Iowa —Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, today announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a [...]
Lowering barriers to scalable multiplex spatial biology
April 20, 2026
The Launch Early Access Program (LEAP) from Leica Microsystems provides supported access to the ATTOAuriga reagent platform Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today that its Launch Early Access Program (LEAP) is now available, offering supported early access to ATTOAuriga, a novel spatial [...]
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
April 18, 2026
Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ) PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, [...]
April 17, 2026
MALDI Biotyper (MBT): Launch of proprietary MBT Easy T Kit for consistent sample transfer to MALDI target plates MALDI Biotyper: Expansion of reference libraries to more than 5,300 species, spanning bacteria, yeasts, filamentous fungi, and mycobacteria MALDI Biotyper: Early KOL access to a novel cloud‑based identification solution, enabling identification against several specialist, expert‑curated libraries MALDI [...]
April 17, 2026
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new Repligen Training & Innovation Center (“RTIC”) at its OPUS® Pre-packed Chromatography Columns manufacturing facility in Breda, the Netherlands. The RTIC buildout, which features product exhibits and purpose-built demonstration areas, was designed to [...]
April 17, 2026
Saint Germain-en-Laye, France, San José, USA, and Helsinki, Finland – Life Science Newswire – Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput antimicrobial resistance (AMR) surveillance from environmental samples. This collaboration unites Takara Bio’s scalable instrumentation with Resistomap’s environmental AMR intelligence to address [...]

